Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

U.S. State, Local Government Lawsuits over Opioids Face Uphill Battle

By Nate Raymond (Reuters) | on June 12, 2017 | 0 Comment
Latest News
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

In announcing the lawsuit, Ohio Attorney General DeWine argued the drugmakers’ deception continued “despite the warnings in the small print of their very own drug labels and package inserts which clearly contradict their marketing.”

You Might Also Like
  • U.S. State Attorneys General Probe Opioid Drug Companies
  • More than One-Third of U.S. Adults Prescribed Opioids in 2015
  • Opioids No Better than NSAIDs for Chronic Back or Arthritis Pain

“You can give a great warning but undercut it, and that can go to the fraud point,” Tobias said.

In September, the federal judge overseeing Chicago’s opioid lawsuit allowed the case to proceed after finding the city alleged sufficient facts to back its claim that the companies deceived healthcare providers.

Fraudulent marketing was also at issue a decade ago when Purdue paid more than $600 million and pleaded guilty to misbranding the opioid drug OxyContin by falsely touting it as less addictive than rival products.

Along with their arguments based on FDA approval, the drug companies are also taking aim at state and local governments’ use of private plaintiffs’ lawyers to bring opioid lawsuits in exchange for a percentage of any settlement or judgment.

Five law firms are representing Ohio on a contingency-fee basis. Drugmakers have argued their constitutional due process rights are violated when profit-seeking private lawyers, as opposed to public servants, pursue government cases seeking large damages.

The companies scored a victory in 2016 when a judge invalidated one such agreement between former New Hampshire Attorney General Joseph Foster and the law firm Cohen Milstein Sellers & Toll.

Now on appeal to the New Hampshire Supreme Court, the ruling effectively blocked the state from filing a lawsuit. A similar bid is underway to invalidate a contingency fee deal between the law firm Simmons Hanly Conroy and New York’s Suffolk County.

Paul Hanly, of Simmons Hanly Conroy, said the drug companies were making a “completely frivolous argument” that would not deter opioid litigation. He is representing three other New York counties in opioid lawsuits and preparing to bring lawsuits on behalf of several more. “What we’re seeing is a feeding frenzy as plaintiffs’ lawyers are looking around and seeing this high-profile litigation and are clamoring to get in,” Hanly said.

Pages: 1 2 | Single Page

Topics: AddictionFederal GovernmentLawsuitLegalMedicationOhioOpioidsOverdosePainpainkillersPatient CarePharmaceutical

Related

  • Toxin-Induced Hypotension Treatment Tips

    July 3, 2025 - 0 Comment
  • Prehospital Buprenorphine Is a Powerful Tool in the Opioid-Crisis Fight

    June 4, 2025 - 0 Comment
  • May 2025 News from the College

    May 6, 2025 - 0 Comment

Current Issue

ACEP Now: July 2025

Download PDF

Read More

No Responses to “U.S. State, Local Government Lawsuits over Opioids Face Uphill Battle”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Current Issue

ACEP Now: July 2025

Download PDF

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603